logo
Plus   Neg
Share
Email

Walgreens, Postmates Expand On-demand Delivery Service

Walgreens and Postmates have expanded on-demand delivery service to 7,000 stores nationwide to address the rising need for home delivery.

Consumers can get health and wellness items, including select over-the-counter medications, and other household essentials and convenience products they need delivered to them from the Walgreens stores.

But, Postmates delivery service from Walgreens stores is not available in Alaska, Hawaii and Puerto Rico.

"Because of Postmates' non-contact delivery options for certain items, Postmates drivers will leave deliveries on doorsteps, keeping these transactions completely contact-less, with no personal interaction required," said Walgreens President, Richard Ashworth.

Walgreens said that customers should visit Postmates website or download the Postmates mobile app to order any of the items available. Customers can get access to unlimited free delivery when they subscribe to Postmates membership service, Postmates Unlimited, for $9.99 per month.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Hyundai Motor has launched a new IONIQ brand dedicated to battery electric vehicles, as the automaker is accelerating its efforts to gain a share in the fast-growing global EV market. Under the IONIQ brand, Hyundai plans to introduce three new dedicated electric vehicle models over the next four years. Hyundai is South Korea's largest automaker. Amazon.com, Inc. is in talks with mall operator Simon Property Group, Inc. to use the abandoned anchor departmental stores of JC Penny and Sears at their malls as fulfillment centers, reports said. This is expected to help the e-commerce giant in boosting their last mile delivery, which is the last leg of the delivery process. The U.S. Food and Drug Administration announced the approval of Trevena Inc.'s Olinvyk (oliceridine), a new opioid for intravenous use in hospitals or other controlled clinical settings. Olinvyk is an opioid agonist to manage moderate to severe acute pain in adults, where the pain is severe enough to require an intravenous opioid and for whom alternative treatments are inadequate.
RELATED NEWS
Follow RTT